Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • Report
  • 280 Pages
From
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 244 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 123 Pages
From
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 1100 Pages
From
Thyroid Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2018

  • Report
  • 567 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018

  • Report
  • 63 Pages
From
Anal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Anal Cancer - Pipeline Review, H1 2018

  • Report
  • 237 Pages
From
Merkel Cell Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Review, H2 2017

  • Report
  • 346 Pages
From
Thyroid Cancer - Pipeline Insight, 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Merkel Cell Carcinoma - Pipeline Review, H1 2017 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Review, H1 2017

  • Report
  • 257 Pages
From
Non-Hodgkin Lymphoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H1 2018

  • Report
  • 2186 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018

  • Report
  • 498 Pages
From
Follicular Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Review, H2 2016

  • Report
  • 540 Pages
From
Prostate Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2018

  • Report
  • 2069 Pages
From
Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

  • Report
  • 710 Pages
From
Loading Indicator
adroll